Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen Buys Rights to Acorda’s MS Pill Outside U.S.
Bloomberg
Wednesday, July 1, 2009 - 9:04am
tags:
Biogen Idec, Acorda Therapeutics, Fampridine-SR, MS
U.S. group questions AstraZeneca's Crestor patent
Yahoo/Reuters
Wednesday, July 1, 2009 - 9:01am
tags:
AstraZeneca, Crestor, patents
AMAG Pharmaceutical's Anemia Treatment wins FDA Approval
WSJ Online
Tuesday, June 30, 2009 - 7:06pm
tags:
Amag Pharmaceuticals, anemia, Feraheme, FDA
Pozen seeks FDA approval for pain drug
Yahoo/AP
Tuesday, June 30, 2009 - 7:05pm
tags:
Pozen, FDA, AstraZeneca, painkillers, Vimovo
Study in mice sheds light on Ambien side effects
Reuters
Tuesday, June 30, 2009 - 4:39pm
tags:
Ambien, insomnia, Sanofi
Novavax in deal with Spain to complete development, sell genetically engineered flu vaccines
Yahoo/AP
Tuesday, June 30, 2009 - 4:38pm
tags:
Novavax, Spain, vaccines, Flu
Here We Go Again With Tysabri
Motley Fool
Tuesday, June 30, 2009 - 3:37pm
tags:
Tysabri, MS, Elan, Biogen Idec, PML
BioSante to buy Cell Genesys for $38M in stock
Bizjournals.com
Tuesday, June 30, 2009 - 3:36pm
tags:
BioSante, Cell Genesys
One-Drug Wonders Deserve a Spot in Your Portfolio
Motley Fool
Tuesday, June 30, 2009 - 3:34pm
tags:
drug stocks, Omrix, JNJ, Gilead Sciences, CV Therapeutics, ImClone, Eli Lilly, Cougar Biotechnology
FDA Panel Recommends Smaller Doses of Painkillers
WSJ Online
Tuesday, June 30, 2009 - 3:31pm
tags:
FDA, painkillers
Abbott plans to appeal $1.67B patent order
Yahoo/AP
Tuesday, June 30, 2009 - 11:45am
tags:
Abbott Laboratories, appeals, JNJ, patents
AMAG: FDA Delays Feraheme Decision
TheStreet.com
Tuesday, June 30, 2009 - 11:40am
tags:
FDA, Feraheme, Amag Pharmaceuticals
Drug stocks inch up; Vical, Geron soar
Marketwatch
Tuesday, June 30, 2009 - 11:38am
tags:
drug stocks, Vical, Geron
Abbott Falls After Losing Patent Case
Seeking Alpha
Tuesday, June 30, 2009 - 11:31am
tags:
patents, JNJ, Abbott Laboratories
Vical says swine flu vaccine works in mice
Marketwatch
Tuesday, June 30, 2009 - 8:22am
tags:
Vical, vaccines, swine flu, H1N1
XenoPort says positive trial of spinal cord drug
Marketwatch
Tuesday, June 30, 2009 - 8:21am
tags:
XenoPort, drug trials
Geron, GE Healthcare enter stem-cell pact
Marketwatch
Tuesday, June 30, 2009 - 8:20am
tags:
Geron, stem cells, GE Healthcare, partnerships
Sanofi to Seek Advice on How to Further Study Lantus
Bloomberg
Tuesday, June 30, 2009 - 8:07am
tags:
Lantus, diabetes, insulin, Sanofi
Obama-Proof: Pfizer, Bristol-Myers and Teva
TheStreet.com
Tuesday, June 30, 2009 - 8:05am
tags:
Obama, Pfizer, Bristol-Myers Squibb, Teva Pharmaceuticals
17 Reasons Why Bayer Might Acquire Spectrum Pharmaceuticals
Seeking Alpha
Tuesday, June 30, 2009 - 8:04am
tags:
Bayer, Spectrum Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.